Books > Medicine > Clinical & internal medicine > Medical diagnosis
|
Not currently available
Genome-Based Diagnostics - Clarifying Pathways to Clinical Use: Workshop Summary (Paperback)
Loot Price: R816
Discovery Miles 8 160
|
|
Genome-Based Diagnostics - Clarifying Pathways to Clinical Use: Workshop Summary (Paperback)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
The sequencing of the human genome and the identification of
associations between specific genetic variants and diseases have
led to an explosion of genomic-based diagnostic tests. These tests
have the potential to direct therapeutic interventions, predict
risk or onset of disease, or detect residual disease. As research
progresses and an increasing number of associations are found,
further tests will be developed that can aid in providing
personalized treatment options for patients. However, the adoption
of genomic diagnostic tests by health care providers has been
limited due to a lack of evidence regarding the clinical utility of
many tests. Health funders and practitioners lack the data
necessary to distinguish which tests can improve practice or the
clinical settings in which tests will provide the greatest value.
The Roundtable on Translating Genomic-Based Research for Health
held a workshop in November 2010 to determine what evidence is
needed and how it is viewed by different stakeholders in order to
develop genomic diagnostic tests of clinical value. Genome-Based
Diagnostics summarizes the presentations and discussions that took
place throughout the workshop. Two presentations, in particular,
sparked extensive discussion. One presentation proposed that all
genomic diagnostic tests be reviewed and approved by the Food and
Drug Administration. The other observed that venture capitalists
are no longer investing substantially in the development of genomic
diagnostic tests because of a lack of clarity surrounding
regulatory and reimbursement pathways. Both presentations suggested
the need for major changes in the systems used to develop,
regulate, and reimburse genomic diagnostic tests. The report also
presents the perspectives of different stakeholders in the
development of genomic diagnostic tests. Each stakeholder group has
a different set of needs and issues of importance, yet
commonalities among them are apparent, such as the need to put
patients and health outcomes at the center of discussion and
action. Table of Contents Front Matter 1 Introduction 2 Calls for
Change 3 Test Developers 4 Patients 5 Payers 6 Regulation,
Reimbursement, and Public Health 7 Discussion of Major Proposals
References Appendix A: Workshop Agenda Appendix B: Speaker
Biographical Sketches Appendix C: Statement of Task Appendix D:
Registered Attendees
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.